CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+16.06%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.88B
AUM Growth
+$7.88B
(+14%)
Cap. Flow
-$29.8M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
72.68%
Holding
127
New
5
Increased
27
Reduced
38
Closed
14
Top Buys
| 1 |
Microsoft
MSFT
|
$371M |
| 2 |
LivaNova
LIVN
|
$8.09M |
| 3 |
Takeda Pharmaceutical
TAK
|
$7.46M |
| 4 |
Centene
CNC
|
$4.97M |
| 5 |
Illumina
ILMN
|
$4.51M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$330M |
| 2 |
Visa
V
|
$16.7M |
| 3 |
HDFC Bank
HDB
|
$10.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$9.85M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$8.53M |
Sector Composition
| 1 | Financials | 22.43% |
| 2 | Consumer Discretionary | 16.91% |
| 3 | Healthcare | 14.47% |
| 4 | Consumer Staples | 10.11% |
| 5 | Communication Services | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teladoc Health
TDOC
$1.37B
| $5.83M | 0.07% | 104,834 +46,827 | +81% | +$2.6M |
|
|
PTLA
52
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.53M | 0.07% | 159,366 | – | – |
|
53
TSMC
TSM
$1.2T
| $5.49M | 0.07% | 134,052 +303 | +0.2% | +$12.4K |
|
54
NovoCure
NVCR
$1.38B
| $5.21M | 0.07% | 108,059 -33,035 | -23% | -$1.59M |
|
55
Exact Sciences
EXAS
$8.98B
| $5.11M | 0.06% | 58,932 -9,399 | -14% | -$814K |
|
|
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.06M | 0.06% | 191,544 | – | – |
|
|
LHCG
57
DELISTED
LHC Group LLC
LHCG
| $5.06M | 0.06% | 45,657 +8,000 | +21% | +$887K |
|
58
Insulet
PODD
$23.9B
| $5.01M | 0.06% | 52,672 +26,678 | +103% | +$2.54M |
|
|
VCRA
59
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.9M | 0.06% | 155,058 +120,045 | +343% | +$3.8M |
|
60
Cigna
CI
$80.3B
| $4.83M | 0.06% | 30,018 -23,807 | -44% | -$3.83M |
|
61
TherapeuticsMD
TXMD
$12.8M
| $4.82M | 0.06% | 989,834 +287,959 | +41% | +$1.4M |
|
|
STML
62
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.6M | 0.06% | 358,082 +225,654 | +170% | +$2.9M |
|
|
63
Illumina
ILMN
$15.8B
| $4.51M | 0.06% | +14,505 | New | +$4.51M |
|
|
DERM
64
DELISTED
Dermira, Inc.
DERM
| $4.4M | 0.06% | 324,884 +21,932 | +7% | +$297K |
|
|
ONCE
65
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.26M | 0.05% | 37,392 -4,232 | -10% | -$482K |
|
66
Jazz Pharmaceuticals
JAZZ
$7.75B
| $4.26M | 0.05% | 29,774 -2,290 | -7% | -$327K |
|
|
AIMT
67
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $4.08M | 0.05% | 182,709 +48,377 | +36% | +$1.08M |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $3.97M | 0.05% | 123,514 | – | – |
|
|
GWPH
69
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.96M | 0.05% | 23,473 -2,229 | -9% | -$376K |
|
70
Dynavax Technologies
DVAX
$1.19B
| $3.63M | 0.05% | 496,412 +6,049 | +1% | +$44.2K |
|
71
Collegium Pharmaceutical
COLL
$1.22B
| $3.57M | 0.05% | 236,021 | – | – |
|
72
Glaukos
GKOS
$5.5B
| $3.47M | 0.04% | 44,265 -5,010 | -10% | -$393K |
|
73
Incyte
INCY
$16.5B
| $3.33M | 0.04% | 38,726 -5,753 | -13% | -$495K |
|
74
Insmed
INSM
$28.8B
| $3.29M | 0.04% | 113,110 | – | – |
|
75
DexCom
DXCM
$29.5B
| $3.21M | 0.04% | 26,949 | – | – |
|